NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DoubleVerify Holdings, Inc. (“DoubleVerify” or the “Company”) (NYSE: DV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Hong Kong, July 14, 2025 (GLOBE NEWSWIRE) -- GRANDE GROUP LIMITED (“GRAN” or the “Company”) (Nasdaq: GRAN), a Hong Kong-based financial services provider which principally engages in the provision of corporate finance advisory services and IPO sponsor services through its Hong Kong subsidiary, Grande Capital Limited, today announced the full exercise of the over-allotment option (the “Over-allotment”) by the underwriter (the “Underwriter”) of its initial public offering (the “Offering”) to purchase an additional 281,250 Class A ordinary shares (the “Class A Ordinary Shares”) of the Company at the public offering price of US$5.00 per share and the closing of such …

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- On June 25, 2025 investors in CTO Realty Growth, Inc. (NYSE: CTO) saw the price of their shares significantly decline after Wolfpack Research published CTO: The B. Riley Of REITS, accusing CTO of misleading investors about its dividend sustainability and engaging in dubious financial activities.

NEW YORK--(BUSINESS WIRE)---- $IOVA #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Iovance Biotherapeutics, Inc. (“Iovance” or the “Company”) (NASDAQ: IOVA) and reminds investors of the July 14, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

LOS ANGELES , July 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Apple Inc. ("Apple" or "the Company") (NASDAQ: AAPL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between June 10, 2024 and June 9, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 19, 2025.

It's been a while since investors have been able to buy off the discount rack, but the sudden reversal in U.S. markets over the last quarter has left analysts scrambling to update their earnings projections and year-end index targets. While the usual tech sector suspects have led the rally, the S&P 500 and the NASDAQ Composite have both made new all-time highs this month, and surges in speculative assets like Bitcoin indicate that risk-takers are once again whetting their appetites.

“If it was up to me, Tesla would have invested in xAI long ago,” Musk had said on X.

LOS ANGELES , July 14, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Reddit, Inc. ("Reddit" or "the Company") (NYSE: RDDT) for violations of the federal securities laws. Shareholders who purchased the Company's securities between October 29, 2024 and May 20, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 18, 2025.

LOS ANGELES , July 14, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Tempus AI, Inc. ("Tempus" or "the Company") (NASDAQ: TEM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 6, 2024 and May 27, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 12, 2025.

ARCC is a leading BDC, but April's volatility and looming trade uncertainties warrant vigilance as we approach key trade negotiation deadlines. Core earnings are still expected to cover dividends, with management's spillover income and low leverage providing stability and investment firepower to deploy. Yet, ARCC's premium valuation, and potential Fed rate cuts could limit further upside, lowering its risk/reward appeal markedly.

A rising Wall Street chorus believes Apple needs new leadership. Why that's tone deaf.

SAN FRANCISCO, July 14, 2025 (GLOBE NEWSWIRE) -- On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the company's executives. Sookdeo v. Hims & Hers Health, Inc., et al., No. 3:25-cv-05315 (N.D. Cal.) and Yaghsizian v. Hims & Hers Health, Inc. et al., No. 3:25-cv-05321 (N.D. Cal.). Together, the cases seek to represent investors who purchased or otherwise acquired Hims & Hers securities between April 29, 2025 and June 23, 2025.

Merck's impending Verona buyout and recent biotech deals aim to expand its pipeline and cut reliance on Keytruda sales.

JPMorgan plans to charge fintechs for client data access, reshaping the economics of platforms like PayPal, Coinbase and Robinhood.

I retain a Buy rating on Colliers, as the stock can trade at higher valuations benchmarked with engineering peers. The Engineering division has a positive organic growth outlook, considering the potential for cross-selling and geographic expansion. CIGI's roll-up strategy in the Engineering space has been value-accretive, and the firm has the intent to continue with such M&As.

ARCC has one of the most impressive track records of any BDC out there. However, it is getting increasingly risky. I detail why I am downgrading it to Sell.

Chip design software provider Synopsys (SNPS) said Monday it received approval from Chinese regulators for its $35 billion purchase of Ansys (ANSS), clearing the final regulatory hurdle for the deal.

Waters (WAT) shares tumbled over 12% Monday morning after the analytics instruments maker said it plans to buy Becton Dickinson's (BDX) Biosciences & Diagnostic Solutions business in a Reverse Morris Trust transaction valued at $17.5 billion. Becton Dickinson shares were about 2% lower.

LOS ANGELES , July 14, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ: FTRE) for violations of the federal securities laws. Shareholders who purchased the Company's securities between July 3, 2023 and February 28, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 1, 2025.